FDA approves Celgene drug for psoriatic arthritis
from Reuters via Yahoo News
U.S. health regulators approved a Celgene Corp drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. The drug, known chemically as apremilast, will be sold under the brand name Otezla. It is also being studied by the U.S. biotechnology company as a treatment for psoriasis and ankylosing spondylitis.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063